<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03863899</url>
  </required_header>
  <id_info>
    <org_study_id>305/2018</org_study_id>
    <nct_id>NCT03863899</nct_id>
  </id_info>
  <brief_title>Analgesia in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI)</brief_title>
  <acronym>TF-TAVI</acronym>
  <official_title>Pain Control With Ultrasound-guided Ilioinguinal Iliohypogastric Nerve Block Compared With Local Anesthesia Infiltration in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation (TF-TAVI): a Prospective, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ilioinguinal and iliohypogastric (ILIH) nerve blocks are frequently performed for analgesia
      in inguinal surgery.

      The investigators hypothesized that preoperative ultrasound-guided ilioinguinal and
      iliohypogastric (ILIH) nerve blocks will produce better intraoperative analgesia and less
      analgesic requirement postoperatively in comparison to commonly used preoperative local
      infiltration anaesthesia for patients undergoing transfemoral transcatheter aortic valve
      implantation (TF-TAVI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a prospective, randomized trial.

      The patients will be randomized to one of the 2 groups:

      Group 1 - NERVE BLOCK. Ultrasound-guided ILIH nerve block will be performed by attending
      anaesthesiologist.

      Group 2 - LOCAL INFILTRATION. Local anaesthetic infiltration of the operative area will be
      performed by operator.

      During surgery patients will receive low-dose propofol infusion in order to achieve conscious
      sedation level, when indicated.

      An extra dose of local anaesthetic drug for infiltration of the surgical field or intravenous
      fentanyl or/and intravenous paracetamol will be given as rescue analgesics in patients
      reporting pain sensation.

      The patients will be observed for 24 hours. The pain at rest will be assessed using numeric
      rating scale (NRS 0 -10; 0 = no pain: 10 = max pain imaginable).

      On the first postoperative day intravenous analgesics will be given on demand (paracetamol 1
      g iv (if NRS &lt;5) and oxycodone 2,5 mg iv (if NRS &gt; or = 5)).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale (NRS)</measure>
    <time_frame>24 hours</time_frame>
    <description>The numeric rating scale will be used to determine the intraoperative and postoperative pain intensity levels of the patients. Pain intensity is scored 0-10 (0=no pain, 10=the worst pain imaginable). The pain intensity will be measured at 5 time points intraoperatively (femoral artery cannulation, aortic valve system introduction, aortic valve system removal, vessel closure devices insertion and the end of the operation) and at 2 time intervals postoperatively (0-12 hours and 12-24 hours).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional intraoperative analgesia consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Fentanyl and paracetamol consumption during the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional postoperative analgesia consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Oxycodone and paracetamol consumption in first 24 hours after the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with analgesia</measure>
    <time_frame>3 days</time_frame>
    <description>Categorical quantification: Yes / No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative and postoperative cost calculations</measure>
    <time_frame>1 year</time_frame>
    <description>Sum of anesthetics and analgesics administered during operation and within first 24 hours after operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound-guided ilioinguinal iliohypogastric nerve block performed by the anaesthesiologist for Transaortic valve implantation (TAVI) insertion with eventual additional intraoperative analgesia (AIA) and/or additional postoperative analgesia (APA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>local anaesthesia infiltration performed by the operator for TAVI insertion with eventual intraoperative additional analgesia (AIA) and/or postoperative analgesia (APA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nerve block</intervention_name>
    <description>drug mixture: 10-15 ml 0.5% ropivacaine plus 5 ml 1% lidocaine plus 1 mg dexamethasone plus 50 ug adrenaline</description>
    <arm_group_label>Nerve block</arm_group_label>
    <other_name>Ultrasound-guided ilioinguinal iliohypogastric nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local infiltration</intervention_name>
    <description>15-20 ml of mixture of 0.5% bupivacaine and 1% lidocaine (1:1)</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <other_name>Local anesthesia infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAVI</intervention_name>
    <description>Insertion of an aortic valve prothesis through the aorta accessed through femoral artery</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_label>Nerve block</arm_group_label>
    <other_name>Transaortic valve implantation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Additional intraoperative analgesia</intervention_name>
    <description>Administration of any analgesics during the operation</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_label>Nerve block</arm_group_label>
    <other_name>AIA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Additional postoperative analgesia</intervention_name>
    <description>Administration of any analgesics within first 24 hours after the operation</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_label>Nerve block</arm_group_label>
    <other_name>APA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with aortic valve stenosis referred for TF-TAVI

          -  using a minimalist approach of local anesthesia or nerve block with conscious sedation

        Exclusion Criteria:

          -  patient's refusal to participate

          -  allergy to local anaesthetic

          -  TF-TAVI requiring general anesthesia or surgical cut-down

          -  patients with major cognitive impairment and inability to assess their pain level in
             Numerical Rating Scale (NRS).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romuald Lango, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Cardiac Anaesthesiolgy UCC of Gdansk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Clinical Centre</name>
      <address>
        <city>Gda≈Ñsk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>March 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Liudmila Hasak, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ilioinguinal Iliohypogastric nerve block</keyword>
  <keyword>local anaesthesia infiltration</keyword>
  <keyword>ultrasound-guided</keyword>
  <keyword>pain control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

